Skip to content

300957.SZ

贝泰妮

SZSE · Consumer Defensive · C 制造业 · CN

CNY 31.05
−1.99%
Ask drillr
  • Sep 2, 2026, 09:48 UTC

    Yunnan Botanee Bio-Technology Group disclosed that as of August 31, 2026, it had repurchased 3.6997 million shares for about 120 million yuan under its buyback program.

  • Aug 24, 2026, 11:45 UTC

    Botanee announced a share buyback alongside its interim dividend.

  • Aug 24, 2026, 10:43 UTC

    Betaini (Yunnan Botanee Bio-Technology Group) announced its H1 2026 results: revenue of 2.592 billion yuan, up 9.27% year-on-year; net profit attributable to shareholders of 292 million yuan, up 18.30% from 247 million yuan in H1 2025; non-recurring-adjusted net profit of 246 million yuan, up 34.85%.

  • Aug 4, 2026, 08:44 UTC

    Betaini announced that as of August 4, 2026, it had repurchased a cumulative 3.3364 million shares through centralized bidding transactions, accounting for 0.7876% of total share capital, with the highest transaction price of 34.67 yuan per share, the lowest transaction price of 29.84 yuan per share, and a total transaction amount of 108 million yuan (excluding transaction fees). The repurchase complies with relevant regulations, and the company will continue to implement the repurchase plan within the repurchase period based on market conditions.